Continuous manufacturing is gaining in momentum within the pharmaceutical industry for many years. Poor compressibility, high drug loads and other conditions may generate the necessity to perform a wet granulation step prior to tableting. However, the process of continuous wet granulation and drying can be challenging to handle e.g. due to potential filter blockage over time, inconsistent drying results or a poor control over the residence time distribution. Furthermore, there were no truly continuously operating dryers available on the market, so far.
After a brief introduction to the highlights and advantages of the QbCon truly continuous drying technology, the audience will learn about different ways to implement continuous manufacturing techniques within their organization. Various approaches, motivations and business cases will be discussed with the aim to recognize the different possibilities to implement CM for their specific production or R&D process.
Independent of the complexity in terms of automation, containment, number of unit operations or even the throughput range, the potential to benefit from continuous manufacturing will be clearly underlined during this presentation.
You should attend this webinar if you want to learn how an innovative truly continuous granulation and drying processes along the complete chain of CM can boost your efficiency in R&D and commercial production and how it may help you to improve quality, reduce costs and to reduce required GmP area - register for this webinar and enjoy the presentation.
Key Learning Objectives
- Different approaches (and drivers) for generics and originals in terms of continuous manufacturing
- Solutions for lowest and high production output demands
- Case studies of implemented CM processes in the pharmaceutical industry
- High containment considerations in continuous granulation and drying
